Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1961 1
1968 3
1973 1
1983 3
1985 1
1986 2
1988 2
1989 2
1992 2
1993 1
1994 3
1995 2
1996 2
1997 1
1998 2
1999 4
2000 5
2001 4
2002 5
2003 5
2004 1
2005 8
2006 3
2007 5
2008 7
2009 14
2010 10
2011 14
2012 8
2013 12
2014 16
2015 18
2016 14
2017 13
2018 13
2019 18
2020 19
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

233 results
Results by year
Filters applied: . Clear all
Page 1
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.
Liu E, Tong Y, Dotti G, Shaim H, Savoldo B, Mukherjee M, Orange J, Wan X, Lu X, Reynolds A, Gagea M, Banerjee P, Cai R, Bdaiwi MH, Basar R, Muftuoglu M, Li L, Marin D, Wierda W, Keating M, Champlin R, Shpall E, Rezvani K. Liu E, et al. Among authors: dotti g. Leukemia. 2018 Feb;32(2):520-531. doi: 10.1038/leu.2017.226. Epub 2017 Jul 20. Leukemia. 2018. PMID: 28725044 Free PMC article.
Interleukin-23 engineering improves CAR T cell function in solid tumors.
Ma X, Shou P, Smith C, Chen Y, Du H, Sun C, Porterfield Kren N, Michaud D, Ahn S, Vincent B, Savoldo B, Pylayeva-Gupta Y, Zhang S, Dotti G, Xu Y. Ma X, et al. Among authors: dotti g. Nat Biotechnol. 2020 Apr;38(4):448-459. doi: 10.1038/s41587-019-0398-2. Epub 2020 Feb 3. Nat Biotechnol. 2020. PMID: 32015548 Free PMC article.
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.
Ramos CA, Grover NS, Beaven AW, Lulla PD, Wu MF, Ivanova A, Wang T, Shea TC, Rooney CM, Dittus C, Park SI, Gee AP, Eldridge PW, McKay KL, Mehta B, Cheng CJ, Buchanan FB, Grilley BJ, Morrison K, Brenner MK, Serody JS, Dotti G, Heslop HE, Savoldo B. Ramos CA, et al. Among authors: dotti g. J Clin Oncol. 2020 Nov 10;38(32):3794-3804. doi: 10.1200/JCO.20.01342. Epub 2020 Jul 23. J Clin Oncol. 2020. PMID: 32701411 Clinical Trial.
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells.
Du H, Hirabayashi K, Ahn S, Kren NP, Montgomery SA, Wang X, Tiruthani K, Mirlekar B, Michaud D, Greene K, Herrera SG, Xu Y, Sun C, Chen Y, Ma X, Ferrone CR, Pylayeva-Gupta Y, Yeh JJ, Liu R, Savoldo B, Ferrone S, Dotti G. Du H, et al. Among authors: dotti g. Cancer Cell. 2019 Feb 11;35(2):221-237.e8. doi: 10.1016/j.ccell.2019.01.002. Cancer Cell. 2019. PMID: 30753824 Free PMC article.
Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid Tumors.
Fucà G, Reppel L, Landoni E, Savoldo B, Dotti G. Fucà G, et al. Among authors: dotti g. Clin Cancer Res. 2020 Jun 1;26(11):2444-2451. doi: 10.1158/1078-0432.CCR-19-1835. Epub 2020 Feb 3. Clin Cancer Res. 2020. PMID: 32015021 Free PMC article. Review.
An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines.
Ott PA, Dotti G, Yee C, Goff SL. Ott PA, et al. Among authors: dotti g. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e70-e78. doi: 10.1200/EDBK_238001. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099621 Free article. Review.
Engineering PD-1-Presenting Platelets for Cancer Immunotherapy.
Zhang X, Wang J, Chen Z, Hu Q, Wang C, Yan J, Dotti G, Huang P, Gu Z. Zhang X, et al. Among authors: dotti g. Nano Lett. 2018 Sep 12;18(9):5716-5725. doi: 10.1021/acs.nanolett.8b02321. Epub 2018 Jul 31. Nano Lett. 2018. PMID: 30063143
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed N. Hegde M, et al. Among authors: dotti g. J Clin Invest. 2016 Aug 1;126(8):3036-52. doi: 10.1172/JCI83416. Epub 2016 Jul 18. J Clin Invest. 2016. PMID: 27427982 Free PMC article.
233 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page